Singapore: Phylogica has received a core patent in Australia (Registration no: 2009251209; Divisional of AU 2008200790)...
Singapore: In a bid to shift its focus from technology development to sales, Australia's top medical device manufacturer...
Singapore: In a move to venture into the global market, Australia's leading healthcare logistics provider STL Warehousin...
Singapore: GI Dynamics received conditional approval from the US FDA to commence a pivotal clinical trial of the EndoBar...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
Singapore: Australia's Medical Research Commercialization Fund (MRCF) and the Uniseed Commercialization Fund have jointl...
Singapore: US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditio...
Singapore: Medical technology company iSonea launched its first asthma management smartphone app, AsthmaSense, for iPhon...
Singapore: Bionomics Limited launched a phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ...
After witnessing a turbulent year of 2009-10, the focus of Australia-based Sigma Pharmaceuticals in 2011 was restructu...
There is no reliable diagnostic blood test for ovarian cancer. The current market gold standard, CA125, is used as an ai...
Singapore: Australian National University (ANU) has granted an exclusive license to vaccine development company, BioDiem...
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...
Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...
Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...
